Belite Bio, Inc Operating Cash Flow
Belite Bio, Inc (BLTE) reported Operating Cash Flow of -$36.99 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-03-31
| Period end | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|
| 2025-12-31 | -$36.99M 20-F · filed 2026-03-31 |
| 2024-12-31 | -$29.23M 20-F · filed 2026-03-31 |
| 2023-12-31 | -$29.84M 20-F · filed 2026-03-31 |
| 2022-12-31 | -$11.46M 20-F · filed 2025-03-17 |
| 2021-12-31 | -$7.47M 20-F · filed 2024-03-12 |
| 2020-12-31 | -$4.44M 20-F · filed 2023-03-31 |